Inventor
PLOWMAN GREGORY D
US36 patents
⚠️ This page may combine multiple inventors who share the name “PLOWMAN GREGORY D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUGEN INC
11 patentsUS5804396ASep 8, 1998
Assay for agents active in proliferative disorders
SUGEN INC480 citations99
US6388063B1May 14, 2002
Diagnosis and treatment of SAD related disorders
SUGEN INC16 citations74
US6228641B1May 8, 2001
Diagnosis and treatment of PTP04 related disorders
SUGEN INC6 citations73
US6818440B2Nov 16, 2004
Diagnosis and treatment of alk-7 related disorders
SUGEN INC7 citations71
US5830648ANov 3, 1998
Assay and method for transcript imaging
SUGEN INC5 citations63
US7115710B2Oct 3, 2006
Diagnosis and treatment of PTP related disorders
SUGEN INC6 citations62
US6136581AOct 24, 2000
Kinase genes and uses
SUGEN INC4 citations54
US6844177B2Jan 18, 2005
Diagnosis and treatment of PTP04 related disorders
SUGEN INC0 citations51
US6576442B1Jun 10, 2003
rdgB proteins and related products and methods
SUGEN INC0 citations50
US6117673ASep 12, 2000
RDGB proteins and related products and methods
SUGEN INC1 citations50
US6342593B1Jan 29, 2002
Diagnosis and treatment of ALP related disorders
SUGEN INC0 citations48
BRISTOL MYERS SQUIBB CO
5 patentsUS5811098ASep 22, 1998
Antibodies to HER4, human receptor tyrosine kinase
BRISTOL MYERS SQUIBB CO123 citations95
US5416192AMay 16, 1995
Epithelins: novel cysteine-rich growth modulating proteins
BRISTOL MYERS SQUIBB CO29 citations92
US5830995ANov 3, 1998
Fanphiregulins: a family of heparin-binding epithelial cell growth factors
BRISTOL MYERS SQUIBB CO65 citations91
US5965723AOct 12, 1999
DNA encoding epithelins
BRISTOL MYERS SQUIBB CO4 citations74
US5885961AMar 23, 1999
Methods of using epithelins to modulate cell proliferation
BRISTOL MYERS SQUIBB CO1 citations63
LIANG WEI-CHING
4 patentsUS8962275B2Feb 24, 2015
Anti-α5β1 antibodies and uses thereof
LIANG WEI-CHING9 citations83
US8840887B2Sep 23, 2014
Antibodies
LIANG WEI-CHING1 citations62
US8124740B2Feb 28, 2012
Anti- α5 β1 antibodies and uses thereof
LIANG WEI-CHING2 citations62
US9284376B2Mar 15, 2016
Antibodies
LIANG WEI-CHING0 citations51
EXELIXIS INC
4 patentsUS7993829B2Aug 9, 2011
HPRP4s modifiers of the p53 pathway and methods of use
EXELIXIS INC2 citations56
US6972179B2Dec 6, 2005
RRP sequences and knockout mice and uses thereof
EXELIXIS INC0 citations50
US6927022B2Aug 9, 2005
HADHs as modifiers of the p21 pathway and methods of use
EXELIXIS INC0 citations49
US7049088B2May 23, 2006
PRMTs as modifiers of the p53 pathway and methods of use
EXELIXIS INC1 citations47